This resource from the University of California San Francisco compares tubal sterilization with long-acting reversible contraceptive (LARC) methods like the IUD and Implant.
Written by Brandy Bautista This is part two of our February 2023 Insights written by Angeline Ti. You can read February 2023’s Insights on our website. On March 26th, 2024, the Supreme Court heard oral arguments in Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration. This case directly challenges access to mifepristone across…
Some people prefer to take hormonal birth control without estrogen. This fact sheet highlights the progestin-only options that are available. Spanish: Updated 2022 Reading Grade Level (Flesch-Kincaid Grade Level): 6.2 Sources: CDC – Injectables – US SPR – Reproductive Health. Centers for Disease Control and Prevention. https://www.cdc.gov/reproductivehealth/contraception/mmwr/spr/injectables.html. Published May 20, 2021. Accessed…
Since the Supreme Court overturned Roe v. Wade, medical providers in states where abortion is banned or severely restricted have struggled to understand how state laws apply to them and their patients. This resource from the Abortion Defense Network aims to provide clarification, where possible, of what conduct is permitted in the states where the…
By Joi C. Spaulding MD, MS Opill, a daily progestin-only birth control pill (POP), was first approved for over-the-counter (OTC) use by the United States Food and Drug Administration (FDA) on July 13, 2023. As of March 2024, the pill is now available to people of all ages to purchase at retailers online and in…
Written by Rebecca Wang, JD, Senior Legal Support Counsel and Lauren Paulk, JD, Senior Research Counsel Mandatory reporting is not an evidence-based practice. Neither is punishing providers for a failure to report. Still, healthcare provider reports to Child Protective Services of infants have increased substantially over the last decade.¹ This is despite only two states…